Propranolol treatment of infantile hemangioma is not associated with psychological problems at 7 years of age - 14/12/17
, Saskia Spillekom-van Koulil, MSc, PhD b, c, Catharina Joanna Maria van der Vleuten, MD, PhD a, cAbstract |
Background |
Concern has been raised about the potential long-term effects of propranolol treatment for infantile hemangioma (IH).
Objectives |
We sought to assess psychologic (social, emotional, behavioral, and executive) functioning in children treated with propranolol for IH.
Methods |
Twenty-seven patients with IH (6.1-7.6 years of age) treated with propranolol for ≥6 months during infancy, and without other developmental risk factors, were recruited. Parents completed the Behavior Rating Inventory of Executive Function, Social Emotional Questionnaire, Child Behavior Checklist, and Strengths and Difficulties Questionnaire. For each questionnaire, the number of patients with abnormal scores, based on established cutoff points, was calculated.
Results |
Only 1 child (3.7%) scored outside the normal range. The Hemangioma Severity Scale did not correlate with psychologic problems in these patients. Longer treatment duration was found to correlate with less attention-deficit hyperactivity disorder (ADHD) characteristics (ρ = −0.476; P = .012) and better executive functioning (ρ = −0.466; P = .014).
Limitations |
Exclusion of children born at gestational age <36 weeks or small for gestational age, no reference group and relatively small study size.
Conclusion |
We found no increased risk for psychologic problems at age 7 in IH patients treated with propranolol.
Le texte complet de cet article est disponible en PDF.Key words : adverse effects, central nervous system, development, infantile hemangioma, infants, propranolol, psychologic functioning, treatment
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 77 - N° 1
P. 105-108 - juillet 2017 Retour au numéro
Article précédent
- Reporting of harm and safety results in randomized controlled trials published in 5 dermatology journals
- Cynthia Haddad, Odette Berline Sigha, Bénédicte Lebrun-Vignes, Olivier Chosidow, Laurence Fardet
- Evidence-based recommendations for the management of acne fulminans and its variants
- Tanya Greywal, Andrea L. Zaenglein, Hilary E. Baldwin, Neal Bhatia, Karen A. Chernoff, James Q. Del Rosso, Lawrence F. Eichenfield, Marc H. Levin, James J. Leyden, Diane M. Thiboutot, Guy F. Webster, Sheila Fallon Friedlander
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?